Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 295

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 295
---
 any other payment that would be payable under the Arrangement had such holder not exercised their Dissent Rights in respect of such Common Shares; or   |

| (b) | ultimately are not entitled, for any reason, to be paid Fair Value for such Common Shares, shall be deemed to                                                                                                                           
 have participated in the Arrangement on the same basis as a Shareholder that is not a Dissenting Shareholder and shall be entitled to receive only the consideration contemplated by Section 2.3(a) and Section 2.3(g) hereof that such 
 Dissenting Shareholder would have received pursuant to the Arrangement if such Dissenting Shareholder had not exercised its Dissent Rights.                                                                                             |

| 3.2 | Recognition of Dissenting Shareholders |

| (a) | In no circumstances shall the Purchaser, the Company or any other person be required to recognize a person                                                                                                                                               
 exercising Dissent Rights in respect of any Common Shares unless such person is the registered holder of those Common Shares as of the Record Date and as of the deadline for exercising Dissent Rights in respect of which such rights are sought to be 
 exercised.                                                                                                                                                                                                                                               |

| (b) | For greater certainty, in no case shall the Purchaser, the Company or any other person be required to recognize                                                                                                                                   
 Dissenting Shareholders as holders of Common Shares in respect of which Dissent Rights have been validly exercised after the completion of the transfer under Section 2.3(g), and the names of such Dissenting Shareholders shall be removed from 
 the Company’s central securities register in                                                                                                                                                                                                      |

A-60

| respect of those Common Shares in respect which Dissent Rights have been validly exercised at the same time as the event described in Section 2.3(g) occurs. |

| (c) | In addition to any other restrictions under Chapter XIV – Division I of the QBCA, none of the following                                                                                                                                    
 shall be entitled to exercise Dissent Rights: (i) holders of Incentive Securities, (ii) the holder of the Warrant, and (ii) holders of Common Shares who vote or have instructed a proxyholder to vote such Common Shares in favour of the 
 Arrangement Resolution.                                                                                                                                                                                                                    |

ARTICLE 4 CERTIFICATES AND PAYMENTS

| 4.1 | Payment and Delivery of Consideration |

| (a) | The Company shall, following receipt of the Final Order and final agreement on the Closing Cash Calculation,                                                                                                                                           
 and at least one